G. de Vries

Faculty of Medical Sciences

Telephone:

E-mail:

g.de.vries04 umcg.nl

Research Portal

Publications

Dual mTORC1/2 inhibition sensitizes testicular cancer models to cisplatin treatment

Rosas-Plaza, X., de Vries, G., Meersma, G. J., Suurmeijer, A. J. H., Gietema, J. A., van Vugt, M. A. T. M. & de Jong, S., Feb-2020, In: Molecular cancer therapeutics. 19, 2, p. 590-601 13 p.

Research output: Contribution to journal › Article › Academic › peer-review

Establishment and characterisation of testicular cancer patient-derived xenograft models for preclinical evaluation of novel therapeutic strategies

de Vries, G., Rosas-Plaza, X., Meersma, G. J., Leeuwenburgh, V. C., Kok, K., Suurmeijer, A. J. H., van Vugt, M. A. T. M., Gietema, J. A. & de Jong, S., 3-Nov-2020, In: Scientific Reports. 10, 1, p. 1-15 15 p., 18938.

Research output: Contribution to journal › Article › Academic › peer-review

MDM2 inhibitors sensitize testicular cancer models to mTORC1/2 inhibitors and cisplatin

de Jong, S., de Vries, G., Meersma, G. J., Suurmeijer, A. J. H., van Vugt, M. A. T. M. & Gietema, J. A., Aug-2020. 2 p.

Research output: Contribution to conference › Abstract › Academic

Mechanistic and translational studies to improve cisplatin sensitivity of testicular cancer

de Vries, G., 2020, [Groningen]. 207 p.

Research output: Thesis › Thesis fully internal (DIV)

Testicular cancer: Determinants of cisplatin sensitivity and novel therapeutic opportunities: Determinants of cisplatin sensitivity and novel therapeutic opportunities

de Vries, G., Rosas-Plaza, X., van Vugt, M. A. T. M., Gietema, J. A. & de Jong, S., 1-Aug-2020, In: CANCER TREATMENT REVIEWS. 88, 12 p., 102054.

Research output: Contribution to journal › Review article › peer-review

All (5) publications

View full research profile